Cardiovascular outcomes and rates of fractures and falls among patients with brand-name versus generic L-thyroxine use

被引:0
|
作者
Juan P. Brito
Joseph S. Ross
Yihong Deng
Lindsey Sangaralingham
David J. Graham
Yandong Qiang
Zhong Wang
Xiaoxi Yao
Liang Zhao
Robert C. Smallridge
Victor Bernet
Nilay D. Shah
Kasia J. Lipska
机构
[1] Division of Endocrinology,
[2] Diabetes,undefined
[3] Metabolism,undefined
[4] Nutrition,undefined
[5] Department of Internal Medicine,undefined
[6] Mayo Clinic,undefined
[7] Section of General Internal Medicine and the National Clinician Scholars Program,undefined
[8] Yale School of Medicine,undefined
[9] Department of Health Policy and Management,undefined
[10] Yale School of Public Health,undefined
[11] Center for Outcomes Research and Evaluation,undefined
[12] Yale-New Haven Hospital,undefined
[13] Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery,undefined
[14] Mayo Clinic,undefined
[15] Office of Surveillance and Epidemiology,undefined
[16] Center for Drug Evaluation and Research,undefined
[17] U.S. Food and Drug Administration,undefined
[18] Office of Research and Standards,undefined
[19] Office of Generic Drugs,undefined
[20] Center for Drug Evaluation and Research,undefined
[21] U.S. Food and Drug Administration,undefined
[22] Division of Health Care Policy & Research,undefined
[23] Mayo Clinic,undefined
[24] Division of Endocrinology,undefined
[25] Mayo Clinic,undefined
[26] Optum Labs,undefined
[27] Section of Endocrinology,undefined
[28] Department of Internal Medicine,undefined
[29] Yale School of Medicine,undefined
来源
Endocrine | 2021年 / 74卷
关键词
Generic; Brand; Levothyroxine; Hypothyroidism;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:592 / 602
页数:10
相关论文
共 29 条
  • [1] Cardiovascular outcomes and rates of fractures and falls among patients with brand-name versus generic L-thyroxine use
    Brito, Juan P.
    Ross, Joseph S.
    Deng, Yihong
    Sangaralingham, Lindsey
    Graham, David J.
    Qiang, Yandong
    Wang, Zhong
    Yao, Xiaoxi
    Zhao, Liang
    Smallridge, Robert C.
    Bernet, Victor
    Shah, Nilay D.
    Lipska, Kasia J.
    [J]. ENDOCRINE, 2021, 74 (03) : 592 - 602
  • [2] Generic and Brand-Name L-Thyroxine Are Not Bioequivalent for Children With Severe Congenital Hypothyroidism
    Carswell, Jeremi M.
    Gordon, Joshua H.
    Popovsky, Erica
    Hale, Andrea
    Brown, Rosalind S.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (02): : 610 - 617
  • [3] POTENCY OF BRAND NAME AND GENERIC L-THYROXINE PRODUCTS
    STOFFER, SS
    SZPUNAR, WE
    [J]. CLINICAL CHEMISTRY, 1981, 27 (06) : 1070 - 1070
  • [4] Generic versus brand-name drugs used in cardiovascular diseases
    Manzoli, Lamberto
    Flacco, Maria Elena
    Boccia, Stefania
    D'Andrea, Elvira
    Panic, Nikola
    Marzuillo, Carolina
    Siliquini, Roberta
    Ricciardi, Walter
    Villari, Paolo
    Ioannidis, John P. A.
    [J]. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2016, 31 (04) : 351 - 368
  • [5] Generic versus brand-name cardiovascular drugs: a remarkable update
    Flacco, Maria Elena
    Fragassi, Giorgia
    Manzoli, Lamberto
    [J]. EPIDEMIOLOGY BIOSTATISTICS AND PUBLIC HEALTH, 2015, 12 (04)
  • [6] Generic versus brand-name drugs used in cardiovascular diseases
    Lamberto Manzoli
    Maria Elena Flacco
    Stefania Boccia
    Elvira D’Andrea
    Nikola Panic
    Carolina Marzuillo
    Roberta Siliquini
    Walter Ricciardi
    Paolo Villari
    John P. A. Ioannidis
    [J]. European Journal of Epidemiology, 2016, 31 : 351 - 368
  • [7] Generic vs Name Brand L-Thyroxine Products: Interchangeable or Still Not?
    Hennessey, James V.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (02): : 511 - 514
  • [8] Comparison of Incident Cardiovascular Event Rates Between Generic and Brand L-Thyroxine for the Treatment of Hypothyroidism
    Smallridge, Robert C.
    Sangaralingham, Lindsey R.
    Mwangi, Raphael
    Kusumoto, Fred
    Van Houten, Holly
    Bernet, Victor
    [J]. MAYO CLINIC PROCEEDINGS, 2019, 94 (07) : 1190 - 1198
  • [9] Comparative outcomes of treatment initiation with brand-name versus generic warfarin: A medicare cohort study
    Desai, Rishi J.
    Gopalakrishnan, Chandrasekar
    Dejene, Sara
    Sarpatwari, Ameet
    Levin, Raisa
    Dutcher, Sarah
    Wang, Zhong
    Wittayanukorn, Sara
    Franklin, Jessica M.
    Gagne, Joshua
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 403 - 404
  • [10] Seizure Outcomes Following the Use of Generic versus Brand-Name Antiepileptic DrugsA Systematic Review and Meta-Analysis
    Aaron S. Kesselheim
    Margaret R. Stedman
    Ellen J. Bubrick
    Joshua J. Gagne
    Alexander S. Misono
    Joy L. Lee
    M. Alan Brookhart
    Jerry Avorn
    William H. Shrank
    [J]. Drugs, 2010, 70 : 605 - 621